Valneva SE (WBO:VLA) FFO


WBO:VLA Valneva SE WBO:VLA
56 GF Score
Price €2.23
GF Value €2.46
Valuation Fairly Valued
! 6 Warning Signs
View Full Analysis

What is Valneva SE FFO?

FFO (Funds from operations) only applies to REITs.

WBO:VLA
56GF Score
Valneva SE WBO:VLA
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Valneva SE (WBO:VLA) Overvalued in 2026?

Based on GuruFocus' analysis, Valneva SE stock appears to be undervalued. The current stock price of €2.23 is trading 9.4% below its estimated GF Value™ of €2.46. GuruFocus considers Valneva SE to be Fairly Valued.

Key valuation signals for WBO:VLA:

  • FFO:
  • GF Value™: €2.46 vs. price of €2.23 (9.4% below fair value)
  • GF Score™: 56/100 with 6 warning signs

No single metric tells the full story. See the WBO:VLA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Valneva SE Business Description

Address 12 ter Quai Perrache, Bureaux Convergence, Bat. A, Ilot Saint-Joseph, Lyon, FRA, 69002
Valneva SE is a vaccine company focused on developing life-saving vaccines. Its portfolio includes three vaccines for travelers. The segments of the group are Commercialized vaccines which relate to marketed vaccines, the group's vaccines IXIARO/JESPECT, DUKORAL, IXCHIQ; Covid includes development, manufacturing, & distribution related to the COVID-19 vaccine, Vaccine candidates which relate to research and development programs to generate new approvable products to generate future cash flows from product sales through partnering with pharmaceutical companies; & Technologies and services which relate to services and inventions at a commercialization stage. The company generates majority of its revenue from product sales.
56GF Score

Get the complete analysis for WBO:VLA

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€2.23
Price
€2.46
GF Value